SCHEMBL7253268

SCHEMBL7253268

Cc1cc(Cc2ccccc2)c2ccccc2n1

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.63
NCF1 P14598 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.50
GALR3 O60755 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
ALDH1A1 P00352 2/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
ADAM17 P78536 2/20 0.48
KMT2A Q03164 2/20 0.47
CYP2C19 P33261 1/20 0.46
MEN1 O00255 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
BACE1 P56817 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048648 0.91 CYP1A2 (0.58) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL4048646 0.90 CYP1A2 (0.56) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL3967736 0.89 CYP1A2 (0.54) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL3966339 0.89 CYP1A2 (0.54) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL3966342 0.89 NCF1 (0.56) CYP1A2NCF1SMN1; SMN2RAB9AALDH1A1
SCHEMBL3969728 0.86 CYP1A2 (0.51) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL3964970 0.86 CYP1A2 (0.51) CYP1A2NCF1SMN1; SMN2GALR3HTT
SCHEMBL3970382 0.86 CYP1A2 (0.51) CYP1A2NCF1RAB9AALDH1A1KDM4E
SCHEMBL3967865 0.85 ADAM17 (0.57) CYP1A2SMN1; SMN2ALDH1A1KDM4EADAM17
SCHEMBL3964963 0.85 CYP1A2 (0.50) CYP1A2NCF1SMN1; SMN2GALR3HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003040103-A1 β-SULFONE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-α CONVERTING ENZYME (TACE) BRISTOL-MYERS SQUIBB COMPANY (US) 2003-05-15 WO disclosed